HealthcareServices

Panic Disorders Market Research: Growth Projections and Trends 2030

February 27, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the panic disorders market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Panic Disorders Market size between 2026 and 2035?

The panic disorders market has shown considerable expansion in recent years. Its size is forecast to increase from $11.15 billion in 2025 to $11.73 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.3%. The market’s historical development was characterized by limited awareness of panic disorders, a reliance on traditional in-person therapy, the high cost of medications, a fragmented mental healthcare infrastructure, and low adoption of digital therapy tools.

The panic disorders market is anticipated to show significant expansion over the next few years. Its valuation is projected to reach $15 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.3%. This expansion during the forecast period is attributed to several factors, including the increasing occurrence of anxiety and panic conditions, the growing adoption of telepsychiatry, breakthroughs in virtual reality and neurofeedback treatments, the broadening of online pharmacy and hospital distribution networks, and a heightened demand for customized mental healthcare plans. Prominent trends observed in this period encompass the rising embrace of telepsychiatry and mobile mental health applications, the integration of virtual reality therapy for anxiety disorders, a greater reliance on biofeedback and neurofeedback techniques, the development of personalized medication strategies for panic disorders, and the overall expansion of mental healthcare facilities and hospital services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

Which Drivers Are Impacting Market Performance In The Panic Disorders Market?

The expanding adoption of telehealth is projected to boost the expansion of the panic disorders market in the future. Telehealth involves the use of electronic communication methods, including videoconferencing, phone calls, and secure messaging, to deliver remote healthcare and medical advice. It enables psychotherapy and counseling services for those affected by panic disorders. Through secure videoconferencing platforms, therapists can lead individual sessions, group therapy, or support groups. An example is seen in April 2023, when FAIR Health Inc., a US-based non-profit, reported a 7.3% nationwide increase in telehealth utilization, moving from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the rising use of telehealth is fueling the development of the panic disorders market.

Which Segments Are Contributing To The Growth Of The Panic Disorders Market?

The panic disorders market covered in this report is segmented –

1) By Treatment Type: Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies

2) By Disorder Type: Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder, Panic Disorder With Comorbidities

3) By Age Group: Children And Adolescents, Adults, Elderly

4) By End User: Hospitals, Specialty Mental Health Clinics, Primary Care Clinics, Telehealth And Digital Platforms, Home Healthcare Services

Subsegments:

1) By Pharmacotherapies: Antidepressants, Benzodiazepines, Beta-Blockers

2) By Psychotherapeutic Interventions: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Psychodynamic Therapy, Group And Family Therapy

3) By Digital Or Tech-Enabled Therapies: Mental Health Apps, Telepsychiatry Or Teletherapy, Virtual CBT Programs

What Industry Trends Are Transforming The Panic Disorders Market?

Major companies operating in the panic disorder market are focusing on developing advanced medicines, such as extended-release capsules, to sustain their position. Extended-release capsules are pharmaceutical formulations that release the active ingredient slowly over a period, typically 12 or 24 hours, to treat conditions requiring medication to be taken for an extended duration. For instance, in May 2023, Granules India Ltd., an India-based pharmaceutical company, obtained abbreviated new drug application (ANDA) approval from the US Food & Drug Administration (USFDA) for venlafaxine hydrochloride extended-release capsules. This product demonstrates bioequivalence with the reference-listed drug product (RLD), Effexor XR Extended-Release Capsules, which is manufactured by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the management of conditions including generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). They work by increasing the levels of serotonin and norepinephrine in the brain, with the dosage usually started at 75 mg per day and potentially increased by the doctor as needed.

Who Are The Core Companies Influencing Trends In The Panic Disorders Market?

Major companies operating in the panic disorders market are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc, Sun Pharmaceutical Industries Ltd, H. Lundbeck A/S, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc, Sumitomo Pharma Co Ltd, LIFECARE NEURO PRODUCTS LTD, Merck & Co Inc, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Which Region Is Projected To Lead The Panic Disorders Market During The Forecast Period?

North America was the largest region in the panic disorders market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Panic Disorders Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

Browse Through More Reports Similar to the Global Panic Disorders Market 2026, By The Business Research Company

Mental Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/mental-health-global-market-report

Generalized Anxiety Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795